Onkologie. 2008:2(1):24-27

Follow-up of patients after radical resection of colorectal cancer

Pavel Skalický, Kamil Vysloužil
I. chirurgická klinika LF UP a FN Olomouc

Despite performing curative resection of colorectal cancer, recurrence occurs in about half of such patients. Aside from recurrence of the primary disease, patients operated for colorectal cancer also have a higher risk of developing metachronic cancer in other locations of the colon or rectum. Long-term follow-up after radical resection of colorectal cancer increases patient survival. This is due to early detection of recurrence of tumour disease, which enables curative treatment. The authors address the aims of long-term patient monitoring after operations for colorectal cancer. Based on research from literature and personal experiences, they emphasize the necessity of intensive monitoring and present recommendations of appropriate examination methods, intervals and duration of patient monitoring.

Keywords: colorectal cancer, dispensarization, prognosis, recurrence

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skalický P, Vysloužil K. Follow-up of patients after radical resection of colorectal cancer. Onkologie. 2008;2(1):24-27.
Download citation

References

  1. Griffin M, Bergralh E, Coffey R, Beart R, Metson L. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987; 60: 2318-2324. Go to original source...
  2. Berge T, Ekelund G, Mellner C, Wenckert A. Carcinoma of the colon and rectum in a defined population. Acta Chir Scand 1973; 438(suppl): 1-86.
  3. Weinerman BH, Orr KB. Colorectal cancer: total provincial experience in a defined population. Can J Gastroenterol 1989; 3: 126-130. Go to original source...
  4. Galandiuk S, Wieand H, Moertel C, Cha S, Fitzgibbons R, Pemberton J et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992; 174: 27-32.
  5. Enblad P, Adami H, Glimelius B, Krusemo U, Pahlman L. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer 1990; 65: 2091-2100. Go to original source... Go to PubMed...
  6. Bulow S, Svendsen LB, Mellemgaard A. Metachronous colorectal carcinoma. Br J Surg. 1990; 77: 502-505. Go to original source... Go to PubMed...
  7. Cali R, Pitsch R, Thorson A, Watson P, Tapia P, Blatchford G et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993; 36: 388-398. Go to original source... Go to PubMed...
  8. Evans H, Moller H, Robinson D, Lewis C, Bell C, Hodgson S. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 2001; 50: 647-652. Go to original source... Go to PubMed...
  9. Shureiqi I, Coaksley C, Morris J, Soliman A, Levin B, Lippman S. Effect of age on risk of second primary colorectal cancer. J Nat Cancer Inst 2001; 93: 1264-1266. Go to original source... Go to PubMed...
  10. Green R, Metlay J, Propert K, Catalano P, Mayer R, Haller D. Surveillance for second primary colorectal cancer after adjuvant chemotherapy; an analysis of Intergroup 0089. Ann Int Med 2002; 136: 261-269. Go to original source... Go to PubMed...
  11. Scholefield JH, Steele RJ. Guidelines for follow up after resection of colorectal cancer. Gut 2002; 51: Suppl V: v3-v5. Go to original source... Go to PubMed...
  12. Zauber AG, Bond JH, Winawer SJ. Surveillance of patients with colorectal adenomas or cancer. In Young GP et al. Prevention and early detection of colorectal cancer. Philadelphia, WB. Saunders Comp. Ltd., 1996.
  13. Suzuki K, Dozois RR, Devine RM. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39: 730-636. Go to original source... Go to PubMed...
  14. Ovaska J, Jarvinen H, Kujari, H. Follow-up of patients operated on for colorectal cancer. Am J Surg 1990; 159: 593-596. Go to original source... Go to PubMed...
  15. Kjeldsen B, Kronborg O, Fenger C, Jorgensen O. A prospective randomized study of followup after radical surgery for colorectal cancer. Br J Surg 1997; 84: 666-669. Go to original source... Go to PubMed...
  16. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130: 1062-1067. Go to original source... Go to PubMed...
  17. Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg K. Follow-up after curative surgery for colorectal cacrinoma. Randomizes comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-626. Go to original source... Go to PubMed...
  18. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114: 7-14. Go to original source... Go to PubMed...
  19. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurences of colorectal cancer. Dis Colon Rectum 1998; 41: 1127-1133. Go to original source... Go to PubMed...
  20. Secco G, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002; 28(4): 4418-4423. Go to original source... Go to PubMed...
  21. Lennon T, Houghton J, Northover J. What is the value of clinical follow-up for colorectal cancer patients? The experience of the CRC/NIH CEA second-look trial (abstract). In the proceedings of the Nottingham International Colorectal Cancer Symposium, Nottingham. 1995.
  22. Renehan A, Egger M, Saunders M, O´Dwyer S. Impact on survival of intense follow-up after curative resection of colorectal cancer: systematic review and meta-analysis of randomized trials. Brit Med J 2002; 324: 1-8. Go to original source... Go to PubMed...
  23. Jeffery GM, Hisckey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane review). The Cochrane Library Issue I, Oxford, Update Software, 2003. Go to original source...
  24. Figueredo A, Rumble R, Maroun J, Earle C, Cummings B, McLeod R et al. Follow-up of patients with curative resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3: 26-39. Go to original source... Go to PubMed...
  25. Desch C, Benson A, Somerfield M, Flynn P, Krause C et al. Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 2005; 23: 8512-8519. Go to original source... Go to PubMed...
  26. Van Cutsen EJ, Kataja VV. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 2005; 16: i16-i17. Go to original source... Go to PubMed...
  27. Engstrom PF, Benson AB. NCCN colon cancer clinical practice guidelines in oncology. (Online) http://www.nccn.org.
  28. Anthony T, Simmang C, Hyman N. Practice parameters fo the surveillance and the follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004; 47: 807-817. Go to original source... Go to PubMed...
  29. Tepper J, O´Connell M, Niedzwiecki D et al. Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of intergroup 0114. J Clin Oncol. 2002; 20: 1944-1750. Go to original source... Go to PubMed...
  30. Guillem J, Chessin D, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836. Go to original source... Go to PubMed...
  31. Moertel C, Fleming T, Mac Donald J et al. The value of the CEA test in monitoring patients with resected colon cancers. JAMA 1993; 270: 943-947. Go to original source...
  32. Averbach AM, Sugarbaker PH. Use of tumour makers and radiologic tests in follow-up. In Cohen AM, Winawer SJ. Cancer of the Colon, Rectum and Anus. New York, Mc Grow Hill, 1995.
  33. Tveit KM, Kataja W. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2005; 16: i20-i21. Go to original source... Go to PubMed...
  34. Chau I, Allen M, Cunningham D et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004; 22: 1420-1429. Go to original source... Go to PubMed...
  35. McCormack PM, Giensberg RJ. Current management of colorectal metastases of the lung. Chest Surg Clin North Am 1998; 8: 119-126.
  36. Goldberg R, Fleming T, Tangen C, Moertel C, MacDonald J, Haller D et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Int Med 1998; 129: 27-35. Go to original source... Go to PubMed...
  37. Jernvall P, Makinen M, Karttunen T et al. Microsatellite instability: Impact in cancer pregression in proximal and distal colorectal cancers. Eur J Cancer 1999; 35: 197-201. Go to original source... Go to PubMed...
  38. Allen WL, Johnston, PG. Role of genomic markers in colorectal cancer treatment. J Clin Oncol 2005; 23: 4545-4552. Go to original source... Go to PubMed...
  39. Berlin JD. Targeting vascular endothelial growth factor in colorectal cancer. Oncology 2002; 16(suppl 7): 13-15.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.